Related Experiment Video
Updated: May 13, 2026

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
Published on: March 17, 2023
Lactic acid oligomers (OLAs) as prodrug moieties
1Department of Medicinal Chemistry, University of Vienna, Austria.
Lactic acid oligomers (OLAs) show promise as novel prodrug components. Studies on OLA-ibuprofen conjugates indicate good plasma stability and albumin binding, supporting their potential in drug delivery systems.
Area of Science:
- Biochemistry
- Organic Chemistry
- Pharmaceutical Sciences
Background:
- Prodrug strategies enhance drug delivery and therapeutic efficacy.
- Lactic acid oligomers (OLAs) are biodegradable polymers with potential for drug conjugation.
Purpose of the Study:
- To investigate lactic acid oligomers (OLAs) as novel prodrug moieties.
- To synthesize and characterize OLAs and their drug conjugates.
- To evaluate the plasma stability and albumin adsorption of OLA-drug conjugates.
Main Methods:
- Non-selective oligomerization and block synthesis of lactic acid to tetramers.
- Synthesis of ibuprofen esterified with lactic acid oligomers (LA(1)-ibuprofen).
- In vitro assessment of plasma stability (degradation) and albumin binding.
Main Results:
- Successful synthesis of lactic acid oligomers and LA(1)-ibuprofen ester.
- Demonstrated plasma stability of the OLA-ibuprofen conjugate.
- Significant albumin adsorption observed for the OLA-ibuprofen conjugate.
Conclusions:
- Lactic acid oligomers are effective prodrug moieties.
- OLAylation of ibuprofen results in a stable conjugate with favorable pharmacokinetic properties.
- These findings support the development of OLA-based prodrugs for improved drug delivery.
Related Concept Videos
Prodrugs
Prodrugs help overcome...
Production of Organic Acids
Local Anesthetics: Chemistry and Structure-Activity Relationship
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Oral Drug Delivery Systems: Delayed-Release Systems

